Lixa

About:

Lixa develops revolutionary, scalable solutions for antimicrobial resistance (AMR) and the US$5T per annum biofilm problem.

Website: https://www.lixa.life/

Description:

Lixa solves recurring, problematic microbial infections and contaminations.

Total Funding Amount:

2.2M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Perth, Western Australia, Australia

Founded Date:

2021-01-01

Founders:

Maud Eijkenboom

Number of Employees:

1-10

Last Funding Date:

2022-09-06

IPO Status:

Private

Industries: